Skip to main content
Log in

High mutation rate of foot-and-mouth disease virus treated with hydroxylamine

  • Published:
Archiv für die gesamte Virusforschung Aims and scope Submit manuscript

Summary

It was found experimentally that 39% of the surviving plaque-forming units are mutants when the total infectivity of the treated sample is decreased by one neperian logarithm through inactivation with hydroxylamine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carp, R., andH. Koprowski: Mutation of type 3 poliovirus with nitrous acid. Virology17, 99–109 (1962).

    Article  PubMed  Google Scholar 

  2. Cottral, G. E., R. E. Patty, P. Gailiunas, andF. W. Scott: Relationship of foot-and-mouth disease virus plaque size on cell cultures to infectivity for cattle by intramuscular inoculation. Arch. ges. Virusforsch.18, 276–293 (1966).

    Google Scholar 

  3. Dulbecco, R., andM. Vogt: Plaque formation and isolation of pure lines with poliomyelitis. J. exp. Med.99, 167–182 (1954).

    PubMed  Google Scholar 

  4. Fellowes, O. N.: Hydroxylamine as an inactivating agent for foot-and-mouth disease virus. J. Immunol.96, 772–777 (1966).

    PubMed  Google Scholar 

  5. Fellowes, O. N.: Application of stresses to foot-and-mouth disease virus. Amer. J. vet. Res.28, 1873–1880 (1967).

    PubMed  Google Scholar 

  6. Franklin, R. M., andE. Wecker: Inactivation of some animal viruses by hydroxylamine and the structure of ribonucleic acid. Nature (Lond.)184, 343 (1959).

    Google Scholar 

  7. Freese, E., E. B. Freese, andS. Graham: The oxygen dependent reaction of hydroxylamine with nucleotides and DNA. Biochim. biophys. Acta (Amst.)123, 17–25 (1966).

    Google Scholar 

  8. Mundry, K. W., undA. Gierer: Die Erzeugung von Mutationen des Tabak-mosaikvirus durch chemische Behandlung seiner Nukleinsäurein vitro. Z. Vererbungsl.89, 614–630 (1958).

    PubMed  Google Scholar 

  9. Nottebohm, A., C. A. Gaggero, I. Gomes etR. G. Cunha: Examen antigénique d'un vaccin anti-aphteux inactivé (type “A” Vallée) préparé avec du virus cultivé sur des cellules BHK-21. Bull. Off. int. Epiz.61, (9–10) 919–933 (1964).

    Google Scholar 

  10. Rott, R., undW. Schäfer: Hydroxylamin-Empfindlichkeit des Newcastle Disease Virus (NDV). Z. Naturforsch.17b, 861–862 (1962).

    Google Scholar 

  11. Schäfer, W., undR. Rott: Herstellung von Virusvaccinen mit Hydroxylamin. Z. Hyg. Infekt.-Kr.148, 256–268 (1962).

    Google Scholar 

  12. Schuster, H., undG. Schramm: Bestimmung der biologisch wirksamen Einheit in der RNS des TMV auf chemischem Weg. Z. Naturforsch.13b, 697–704 (1958).

    Google Scholar 

  13. Schuster, H.: The reaction of tobacco mosaic virus ribonucleic acid with hydroxylamine. J. molec. Biol.3, 447–457 (1961).

    PubMed  Google Scholar 

  14. Schuster, H., andH. G. Wittmann: The inactivating and mutagenic action of hydroxylamine on tobacco mosaic virus ribonucleic acid. Virology19, 421–430 (1963).

    Article  PubMed  Google Scholar 

  15. Tessman, I.: Mutagenic treatment of double-and single stranded DNA phages T4 and S13 with hydroxylamine. Virology35, 330–333 (1968).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maes, R., Mesquita, J. High mutation rate of foot-and-mouth disease virus treated with hydroxylamine. Archiv f Virusforschung 29, 77–82 (1970). https://doi.org/10.1007/BF01253882

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01253882

Keywords

Navigation